Özkan, B. Et Al. 2023. Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics , vol.15, no.8 .

Özkan, B., ALTUNTAŞ, E., Ünlü, Ü., Doğan, H. H., Özsoy, Y., & ÇAKIR KOÇ, R., (2023). Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics , vol.15, no.8.

Özkan, Burcu Et Al. "Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus," Pharmaceutics , vol.15, no.8, 2023

Özkan, Burcu Et Al. "Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus." Pharmaceutics , vol.15, no.8, 2023

Özkan, B. Et Al. (2023) . "Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus." Pharmaceutics , vol.15, no.8.

@article{article, author={Burcu Özkan Et Al. }, title={Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus}, journal={Pharmaceutics}, year=2023}